Skip to main content
Premium Trial:

Request an Annual Quote

New Releases: Mar 25, 2009

Premium

Molecular diagnostics developer DxS announced the availability of its TheraScreen KRAS Mutation Kit after receiving clearance from the European Union to sell the product in the region.

DxS' TheraScreen KRAS Mutation Kit runs on Roche's LightCycler 480 Instrument II. The test kit is used by doctors to monitor patient response to two colorectal drugs, Amgen's panitumumab (Vectibix) and Merck's cetuximab (Erbitux).

In addition, DxS annouced it has licensed Roche's LightCycler Adapt Software v1.1 to be used with the TheraScreen test kits, which will allow automated processing of KRAS mutation status tests for colorectal cancer patients.

Manchester, UK-based DxS said that the software will be available for installation in territories where the KRAS Mutation Kit is available for sale through Roche, including Europe, Saudi Arabia, South Africa, and Australia.

Last year DxS and Roche penned a worldwide distribution deal for the TheraScreen KRAS test.

The Scan

More Boosters for US

Following US Food and Drug Administration authorization, the Centers for Disease Control and Prevention has endorsed booster doses of the Moderna and Johnson & Johnson SARS-CoV-2 vaccines, the Washington Post writes.

From a Pig

A genetically modified pig kidney was transplanted into a human without triggering an immune response, Reuters reports.

For Privacy's Sake

Wired reports that more US states are passing genetic privacy laws.

Science Paper on How Poaching Drove Evolution in African Elephants

In Science this week: poaching has led to the rapid evolution of tuskless African elephants.